COMBINATION THERAPY FOR THE TREATMENT OF KRAS-MUTANT PANCREATIC CANCER: PRE-CLINICAL INVESTIGATION OF THE NOVEL INHIBITORS RMC-4550 (SHP2I) AND LY3214996 (ERKI)

Katrin Jana Frank  1     Antonio Mulero-Sánchez  2     Alexandra Berninger  1     Laura Ruiz-Cañas  3, 4     Astrid Bosma  2     Kivanc Görgülü  1     Nan Wu  1     Nina Diakopoulos  1     Ezgi Kaya-Aksoy  1     Dietrich Alexander Ruess  5     Derya Kabacaoglu  1     Fränze Schmidt  1     Larissa Kohlmann  1     Olaf van Tellingen  2     Bram Thijssen  2     Marieke van de Ven  2     Natalie Proost  2     Susanne Kossatz  1, 1     Wolfgang A. Weber  1     Bruno Sainz, Jr  3, 4     René Bernards  2     Hana Algül  1     Marina Lesina  1     Sara Mainardi  2    
1 Technische Universität München, München, Germany
2 The Netherlands Cancer Institute, Amsterdam, Netherlands
3 Universidad Autónoma de Madrid (UAM) and Instituto de Investigaciones Biomédicas "Alberto Sols" (IIBM), Madrid, Spain
4 Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain
5 Medical Center University of Freiburg, Freiburg, Germany

Topic
Digestive Oncology, Hepatobiliary, Histopathology, Pancreas

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing